UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007819 |
|---|---|
| Receipt number | R000009128 |
| Scientific Title | A randomized phase II study of daily administrations versus alternate-day administrations of TS-1 for the elderly patient with completely resected pathological stage IA(T1bN0M0)-IIIA of non-small cell lung cancer |
| Date of disclosure of the study information | 2012/04/25 |
| Last modified on | 2023/07/23 14:36:22 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/04/23 20:30:37 | ||
| 2 | Update | 2013/04/23 20:14:48 | Recruitment status |
|
| 3 | Update | 2015/12/28 21:30:00 | UMIN ID1 |
|
| 4 | Update | 2016/04/20 05:36:32 | Public title Public title |
|
| 5 | Update | 2016/04/20 05:37:56 | Narrative objectives1 Narrative objectives1 |
|
| 6 | Update | 2016/04/20 05:52:12 | Randomization unit Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 7 | Update | 2016/04/20 06:01:45 | TEL TEL Name of primary person or sponsor Organization |
|
| 8 | Update | 2016/12/30 09:49:29 | Recruitment status |
|
| 9 | Update | 2018/10/11 17:28:21 | UMIN ID1 UMIN ID2 |
|
| 10 | Update | 2018/10/14 20:03:25 | Randomization unit Key exclusion criteria |
|
| 11 | Update | 2019/04/12 12:14:24 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of person sending information Name of person sending information Organization Organization Address Address Tel |
|
| 12 | Update | 2019/04/13 21:50:48 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Division name Division name Address Address TEL Organization Organization Division name Address Address Organization1 Address1 Email1 Organization Organization Address Tel |
|
| 13 | Update | 2019/04/13 22:15:38 | Institutions |
|
| 14 | Update | 2019/04/13 22:16:52 | Number of participants that the trial has enrolled |
|
| 15 | Update | 2019/04/13 22:20:57 | Date of IRB Last follow-up date |
|
| 16 | Update | 2019/05/03 22:02:56 | UMIN ID3 |
|
| 17 | Update | 2020/10/15 13:52:20 | Last follow-up date |
|
| 18 | Update | 2022/10/31 20:04:27 | Recruitment status |
|
| 19 | Update | 2023/07/23 13:35:26 | Trial characteristics_1 Trial characteristics_2 Developmental phase Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 20 | Update | 2023/07/23 13:44:45 | Dynamic allocation Institution consideration Concealment |
|
| 21 | Update | 2023/07/23 13:53:35 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 22 | Update | 2023/07/23 13:59:24 | Recruitment status |
|
| 23 | Update | 2023/07/23 14:36:22 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
